Most cited papers from Community Cancer Center

Community Cancer Center

What are the most cited papers from Community Cancer Center?

The most cited paper from Community Cancer Center is "Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial" (David J. Kuter et al., 2008), with 872 citations. Next come "Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells" (595) and "Oncologists' recognition of depression in their patients with cancer." (592).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 68 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial David J. Kuter et al. · The Lancet	Feb 2008	872
2	Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells Adlen Foudi, Konrad Hochedlinger, Denille Van Buren et al. · Nature Biotechnology Open access	5 Dec 2008	595
3	Oncologists' recognition of depression in their patients with cancer. Steven D. Passik, William Dugan, Melanie McDonald et al. · Journal of Clinical Oncology	Apr 1998	592
4	Comparative evaluation of nonesterified and total urinary cholesterol in papilloma and carcinoma of the bladder L.C. Hartmann, J. N. Ingle, L. E. Wold et al. · Open access LMU (Ludwid Maxmilian's Universitat Munchen) Open access	1979	558
5	NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17) Rizwan Romee, Bree A. Foley, Todd R. Lenvik et al. · Blood Open access	13 Mar 2013	554
6	AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP James Bruce Bussel, David J. Kuter, James N. George et al. · New England Journal of Medicine Open access	18 Oct 2006	534
7	Megestrol Acetate for the Prevention of Hot Flashes Charles L. Loprinzi, John C. Michalak, Susan K. Quella et al. · New England Journal of Medicine Open access	11 Aug 1994	506
8	Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2 Miriam Schlee, Jürgen Harder, Bente Köten et al. · Clinical & Experimental Immunology Open access	9 Jan 2008	356
9	Effect of Telecare Management on Pain and Depression in Patients With Cancer Kurt Kroenke, Dale Theobald, Jingwei Wu et al. · JAMA Open access	13 Jul 2010	332
10	Natural History of Stage I Non-Small Cell Lung Cancer Dan J. Raz, Jason A. Zell, S-H.I. Ou et al. · CHEST Journal Open access	16 May 2007	326
11	A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma Aminah Jatoi, Neil M. Ellison, Patrick A. Burch et al. · Cancer	3 Mar 2003	289
12	Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound?guided fine-needle injection in patients with advanced pancreatic carcinoma Kenneth J. Chang, Phuong Nguyen, James A. Thompson et al. · Cancer Open access	15 Mar 2000	288
13	Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity Maureen S. Williams, Mary Burk, Charles L. Loprinzi et al. · International Journal of Radiation OncologyBiologyPhysics	Sep 1996	239
14	Prognostic factors for survival of stage I nonsmall cell lung cancer patients S.‐H.I. Ou, Jason A. Zell, Argyrios Ziogas et al. · Cancer	14 Aug 2007	223
15	Low‐dose, single‐agent temsirolimus for relapsed mantle cell lymphoma Stephen Maxted Ansell, David James Inwards, Kendrith M. Rowland et al. · Cancer Open access	9 Jun 2008	205
16	IKKβ Is Required for Peripheral B Cell Survival and Proliferation Zhiwei Li, Sidne A. Omori, Tord Labuda et al. · The Journal of Immunology Open access	May 2003	205
17	SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes Francis Joseph Giles, Alison Stopeck, Lewis R. Silverman et al. · Blood Open access	25 Mar 2003	199
18	Tetracycline to prevent epidermal growth factor receptor inhibitor‐induced skin rashes Aminah Jatoi, Kendrith M. Rowland, Jeff A. Sloan et al. · Cancer Open access	9 Jun 2008	175
19	Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study Roger G. Owen et al. · The Lancet Haematology Open access	19 Dec 2019	167
20	ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapy Yuan Liu, Weijia Hou, Lian Xia et al. · Chemical Science Open access	2018	149
21	Long-term Results of Response to Therapy, Time to Progression, and Survival With Lenalidomide Plus Dexamethasone in Newly Diagnosed Myeloma Martha Q. Lacy, Morie Abraham Gertz, Angela Dispenzieri et al. · Mayo Clinic Proceedings	Oct 2007	149
22	Barriers and opportunities for gemcitabine in pancreatic cancer therapy Alica K. Beutel, Christopher J. Halbrook · American Journal of Physiology-Cell Physiology Open access	26 Dec 2022	148
23	A phase III study of radiation therapy plus carmustine with or without recombinant interferon-? in the treatment of patients with newly diagnosed high-grade glioma Jan C. Buckner, Paula J. Schomberg, William L. McGinnis et al. · Cancer	2001	141
24	Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer Steven E. Schild, William L. McGinnis, David L. Graham et al. · International Journal of Radiation OncologyBiologyPhysics	27 May 2006	135
25	Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma Hung‐Yi Liu, Murray Korc, Chien‐Chi Lin · Biomaterials Open access	7 Jan 2018	133
26	Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints R. Meier, Daniel A. Bloch, Cristian Cotrutz et al. · International Journal of Radiation OncologyBiologyPhysics Open access	Jun 2018	132
27	Receptor-Mediated Adenylyl Cyclase Activation Through XLαs, the Extra-Large Variant of the Stimulatory G Protein α-Subunit Murat Bastepe, Yasemin Güneş, Beatriz Pérez‐Villamil et al. · Molecular Endocrinology Open access	Aug 2002	128
28	MAGE-A1-, MAGE-A10-, and gp100-Derived Peptides Are Immunogenic When Combined with Granulocyte-Macrophage Colony-Stimulating Factor and Montanide ISA-51 Adjuvant and Administered as Part of a Multipeptide Vaccine for Melanoma Kimberly A. Chianese‐Bullock, Jennifer Pressley, Courtney F. Garbee et al. · The Journal of Immunology	Mar 2005	126
29	Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma Domingo G. Pérez, Vera Jean Suman, Tom R. Fitch et al. · Cancer Open access	18 Dec 2008	126
30	A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis Luann K. Rocke, Charles L. Loprinzi, Jeraldine K. Lee et al. · Cancer Open access	Oct 1993	123
31	Thiol–ene click chemistry: a biocompatible way for orthogonal bioconjugation of colloidal nanoparticles Yuan Liu, Weijia Hou, Hao Ran Sun et al. · Chemical Science Open access	2017	118
32	A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics Mary Beth Wilwerding, Charles L. Loprinzi, James A. Mailliard et al. · Supportive Care in Cancer	Mar 1995	117
33	Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC Shannon S. Zhang, Misako Nagasaka, Viola Weijia Zhu et al. · Lung Cancer Open access	12 Jun 2021	116
34	Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma Maurizio Zangari, Elias J. Anaissie, Alison Stopeck et al. · Clinical Cancer Research	2004	116
35	A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers Angelika Beate Riemer, Derin B. Keskin, Guanglan Zhang et al. · Journal of Biological Chemistry Open access	9 Jul 2010	113
36	Understanding the role of cancer worry in creating a “teachable moment” for multiple risk factor reduction Colleen M. McBride, Elaine Puleo, Kathryn I. Pollak et al. · Social Science & Medicine Open access	28 Nov 2007	109
37	Definitions of Hot Flashes in Breast Cancer Survivors Gwen Finck, Debra L. Barton, Charles L. Loprinzi et al. · Journal of Pain and Symptom Management Open access	Nov 1998	106
38	A Pilot Survey of Aberrant Drug-Taking Attitudes and Behaviors in Samples of Cancer and AIDS Patients Steven D. Passik, Kenneth L. Kirsh, Margaret V. McDonald et al. · Journal of Pain and Symptom Management Open access	Apr 2000	105
39	Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164 Dung Thi Le, Luis Alberto Diaz, Tae Won Kim et al. · European Journal of Cancer	24 Feb 2023	103
40	FAMILY ADJUSTMENT FOLLOWING DISCLOSURE OF HOMOSEXUALITY BY A MEMBER: THEMES DISCERNED IN NARRATIVE ACCOUNTS Jeff A. Beeler, Vicky DiProva · Journal of Marital and Family Therapy	Oct 1999	99
41	Evaluation of shark cartilage in patients with advanced cancer Charles L. Loprinzi, Ralph Levitt, Debra L. Barton et al. · Cancer	24 May 2005	97
42	The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial Thomas H. Price, Lawrence T. Goodnough, William Ralph Vogler et al. · Transfusion	1996	95
43	Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype Toni M. Green, Mary L. Alpaugh, Sanford H. Barsky et al. · BioMed Research International Open access	2015	94
44	Moving from IMRT QA measurements toward independent computer calculations using control charts Todd A. Pawlicki, Sua Yoo, Laurence Edward Court et al. · Radiotherapy and Oncology	12 Aug 2008	92
45	Davydov splitting and singlet fission in excitonically coupled pentacene dimers Bettina S. Basel, Constantin Hetzer, Johannes Zirzlmeier et al. · Chemical Science Open access	2019	90
46	A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma Edith A. Perez, David W. Hillman, Philip J. Stella et al. · Cancer Open access	2000	86
47	Fxr signaling and microbial metabolism of bile salts in the zebrafish intestine Jia Wen, Gilberto Padilla Mercado, Alyssa Volland et al. · Science Advances Open access	23 Jul 2021	83
48	A Tomato-Based, Lycopene-Containing Intervention for Androgen-Independent Prostate Cancer: Results of a Phase II Study from The North Central Cancer Treatment Group Aminah Jatoi, Patrick A. Burch, David W. Hillman et al. · Urology	Feb 2007	83
49	Determining the effectiveness of a clinical-practice intervention in improving the control of pain in outpatients with cancer Rachel Trowbridge, William Dugan, Stephen J. Jay et al. · Academic Medicine	Sep 1997	81
50	Phase II study of SU5416—a small‐molecule, vascular endothelial growth factor tyrosine‐kinase receptor inhibitor—in patients with refractory myeloproliferative diseases Francis Joseph Giles, Maureen A. Cooper, Lewis R. Silverman et al. · Cancer Open access	Apr 2003	81

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.